Clonal origin tracing and integrated biomarker analysis in a JAK2V617F-positive essential thrombocythemia patient progressing to T-cell acute lymphoblastic leukemia

Key Points

• The study aims to trace the clonal origin and analyze biomarkers related to disease progression in a specific patient with JAK2V617F-positive essential thrombocythemia.
• Conducted clonal origin tracing
• Performed integrated biomarker analysis
• Documented disease progression from essential thrombocythemia to T-cell acute lymphoblastic leukemia
• Identified clonal lineage transition during progression
• Noted significant biomarker changes associated with disease advancement